Tag Archives: Phase’

Phase 1 human trials suggest breast cancer drug is safe, effective

A new type of breast cancer drug developed by researchers at the University of Illinois Chicago can help halt progression of disease and is not toxic, according to phase 1 clinical trials. The drug is specifically designed for women whose cancer has stopped responding to hormone therapy. The results are published in the journal Breast… Read More »